A study presented at the annual scientific sessions of the American College of Cardiology showed use of aspirin for primary prevention in patients aged 55 years or older who had type 2 diabetes and heart failure was associated with a 10% lower risk of all-cause mortality with or without hospitalization for heart failure. The findings, based on 12,534 UK patients, however, showed aspirin use was linked to a 50% greater likelihood of nonfatal myocardial infarction or stroke.
Study ties aspirin to lower mortality risk in diabetes with HF
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.